Merck launches accelerator programme for AI startups
pharmaphorum
JUNE 30, 2022
Digital technologies are already helping to enable target identification, lead discovery, preclinical development, and clinical development, said Merck. The hope is that by using AI and ML capabilities, the currently unpredictable process of drug development can become much more predictable, and as a result less expensive.
119 
Let's personalize your content